Company registration number SC665707 (Scotland)
PHARMAFAIR LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2025
PAGES FOR FILING WITH REGISTRAR
PHARMAFAIR LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
PHARMAFAIR LIMITED
BALANCE SHEET
AS AT
30 JUNE 2025
30 June 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
6,405
6,405
Cash at bank and in hand
8,012
8,012
14,417
14,417
Creditors: amounts falling due within one year
4
(2,040)
(2,040)
Net current assets
12,377
12,377
Capital and reserves
Called up share capital
100
100
Share premium account
75,000
75,000
Profit and loss reserves
(62,723)
(62,723)
Total equity
12,377
12,377

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 7 July 2025 and are signed on its behalf by:
Mr D Houlihan
Director
Company Registration No. SC665707
PHARMAFAIR LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2025
- 2 -
1
Accounting policies
Company information

Pharmafair Limited is a private company limited by shares incorporated in Scotland. The registered office is 17 Florence Drive, Giffnock,, Glasgow, Scotland,, G46 6UN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.

1.2
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.3
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.4
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.5
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
PHARMAFAIR LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2025
- 3 -
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
6,405
6,405
4
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
2,040
2,040
5
Related party transactions
2025
2024
Amounts due to related parties
£
£
Other related parties
1,020
1,020
2025-06-30 2024-07-01 false false false 07 July 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr D Houlihan M T McCudden SC665707 2024-07-01 2025-06-30 SC665707 2025-06-30 SC665707 2024-06-30 SC665707 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 SC665707 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 SC665707 core:ShareCapital 2025-06-30 SC665707 core:ShareCapital 2024-06-30 SC665707 core:SharePremium 2025-06-30 SC665707 core:SharePremium 2024-06-30 SC665707 core:RetainedEarningsAccumulatedLosses 2025-06-30 SC665707 core:RetainedEarningsAccumulatedLosses 2024-06-30 SC665707 bus:Director1 2024-07-01 2025-06-30 SC665707 2023-07-01 2024-06-30 SC665707 core:CurrentFinancialInstruments 2025-06-30 SC665707 core:CurrentFinancialInstruments 2024-06-30 SC665707 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 SC665707 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 SC665707 bus:FRS102 2024-07-01 2025-06-30 SC665707 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 SC665707 bus:Director2 2024-07-01 2025-06-30 SC665707 bus:FullAccounts 2024-07-01 2025-06-30 xbrli:pure xbrli:shares iso4217:GBP